AI assistant
Sending…
Humacyte, Inc. — Director's Dealing 2022
Apr 5, 2022
33410_dirs_2022-04-05_fec66384-162a-4a3c-917b-447e1e6eb1f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Humacyte, Inc. (HUMA)
CIK: 0001818382
Period of Report: 2022-04-04
Reporting Person: Parikh Shamik J (Chief Medical Officer)
More from Humacyte, Inc.
Share Issue/Capital Change
2026
May 14
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 24
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Mar 19
Major Shareholding Notification
2026
Jan 9
Capital/Financing Update
2025
Dec 16
Capital/Financing Update
2025
Dec 16
Capital/Financing Update
2025
Dec 15
Regulatory Filings
2025
Dec 15